Ładuje się......
Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn's Disease
We present a case of refractory ileocolonic Crohn's disease in a 27-year-old female treated with dual ustekinumab and vedolizumab biologic therapy. She had mucosal healing for the first time in 13 years after a 10-month treatment of ustekinumab overlapped with 6 months of vedolizumab. No side e...
Zapisane w:
| Wydane w: | Case Rep Med |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Hindawi
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698793/ https://ncbi.nlm.nih.gov/pubmed/29250117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5264216 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|